Real-world comparison of doxorubicin–ifosfamide versus gemcitabine–docetaxel regimens in metastatic uterine leiomyosarcoma: a multicenter retrospective study

Abstract Background Uterine leiomyosarcoma is a rare and aggressive malignancy with limited responsiveness to standard therapies. We conducted a real-world, multicenter study to compare the clinical efficacy and safety of two commonly used first-line chemotherapy regimens—doxorubicin–ifosfamide and...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Salih Tunbekici, Gokhan Sahin, Haydar Cagatay Yuksel, Caner Acar, Imge Akın, Hasan Aslanhan, Mert Iscı, Ceren Kabaoglu, Hamit Bal, Abdullah Sakin, Alper Coskun, Mustafa Seyyar, Mehmet Sıddık Dilek, Mahmut Kara, Ali Solmaz, Teyfik Demir, Evrican Zin, Aytac Terzi, Fatih Kus, Ilgın Koc Kus, Zafer Arık, Ali Aytac, Özge Demirkıran, Bilgin Demir, Havva Yesil, Sedat Biter, Tolga Koseci, Ertugrul Bayram, Ahmet Unsal, Ahmet Ozveren, Alper Sevınc, Duygu Ozaskın, Meltem Baykara, Ahmet Unlu, Arıf Kus, Cengiz Karacin, Merih Yalcıner, Galip Can Uyar, Osman Sutcuoglu, Esmanur Kaplan, Teoman Sakalar, Elif Sahin, Gamze Emin, Atilla Yıldırım, Ceren Mordag, Irem ugurlu, Ilhan Hacıbekiroglu, Ibrahim Tunbekici, Pınar Gursoy, Ulus Ali Sanli, Erdem Goker
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Springer 2025-11-01
Σειρά:	Discover Oncology
Θέματα:	Uterine leiomyosarcoma First-line chemotherapy Doxorubicin–ifosfamide Gemcitabine–docetaxel Real-world study Metastatic soft tissue sarcoma
Διαθέσιμο Online:	https://doi.org/10.1007/s12672-025-03886-1
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!